​
​

MeiraGTx (MGTX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

MeiraGTx Revenue Highlights

Latest Revenue (Y)

$14.02M

Latest Revenue (Q)

$10.91M

MeiraGTx Revenue by Period

MeiraGTx Revenue by Year

DateRevenueChange
2023-12-31$14.02M-11.95%
2022-12-31$15.92M-57.77%
2021-12-31$37.70M142.25%
2020-12-31$15.56M17.09%
2019-12-31$13.29M100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31--

MeiraGTx generated $14.02M in revenue during NA 2023, up -11.95% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

MeiraGTx Revenue by Quarter

DateRevenueChange
2024-09-30$10.91M3768.79%
2024-06-30$282.00K-59.54%
2024-03-31$697.00K-65.83%
2023-12-31$2.04M-60.02%
2023-09-30$5.10M44.15%
2023-06-30$3.54M6.18%
2023-03-31$3.33M-163.05%
2022-12-31$-5.29M-209.80%
2022-09-30$4.82M-55.24%
2022-06-30$10.76M91.00%
2022-03-31$5.63M-73.23%
2021-12-31$21.04M202.91%
2021-09-30$6.95M35.79%
2021-06-30$5.12M11.34%
2021-03-31$4.59M21.31%
2020-12-31$3.79M-25.61%
2020-09-30$5.09M105.84%
2020-06-30$2.47M-41.24%
2020-03-31$4.21M-39.37%
2019-12-31$6.94M93.79%
2019-09-30$3.58M80.79%
2019-06-30$1.98M152.46%
2019-03-31$784.96K100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

MeiraGTx generated $10.91M in revenue during Q3 2024, up 3768.79% compared to the previous quarter, and up 308.19% compared to the same period a year ago.

MeiraGTx Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
RYTMRhythm Pharmaceuticals$77.43M$29.08M
ETONEton Pharmaceuticals$31.64M$10.32M
IDYAIDEAYA Biosciences$23.39M-
ANABAnaptysBio$17.16M$30.02M
QUREuniQure$15.84M$2.29M
MGTXMeiraGTx$14.02M$10.91M
KRONKronos Bio$6.29M$2.37M
GBIOGeneration Bio$5.90M$4.09M
FIXXQ32 Bio$1.16M-
KROSKeros Therapeutics$151.00K$37.00K
CCCCC4 Therapeutics--
CNTBConnect Biopharma--
ABOSAcumen Pharmaceuticals--
ERASErasca--
RCKTRocket Pharmaceuticals--
SLDBSolid Biosciences--
EWTXEdgewise Therapeutics--
NUVBNuvation Bio-$727.00K
ELDNEledon Pharmaceuticals--

MGTX Revenue FAQ

What is MeiraGTx’s yearly revenue?

MeiraGTx's yearly revenue for 2023 was $14.02M, representing a decrease of -11.95% compared to 2022. The company's yearly revenue for 2022 was $15.92M, representing a decrease of -57.77% compared to 2021. MGTX's yearly revenue for 2021 was $37.7M, representing an increase of 142.25% compared to 2020.

What is MeiraGTx’s quarterly revenue?

MeiraGTx's quarterly revenue for Q3 2024 was $10.91M, a 3768.79% increase from the previous quarter (Q2 2024), and a 113.80% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $282K, a -59.54% decrease from the previous quarter (Q1 2024), and a -92.03% decrease year-over-year (Q2 2023). MGTX's quarterly revenue for Q1 2024 was $697K, a -65.83% decrease from the previous quarter (Q4 2023), and a -79.09% decrease year-over-year (Q1 2023).

What is MeiraGTx’s revenue growth rate?

MeiraGTx's revenue growth rate for the last 3 years (2021-2023) was -62.82%, and for the last 5 years (2019-2023) was 5.45%.